Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Bill To Protect First Responders from Toxic Firefighter Foam Chemicals Moves Forward In Senate March 18, 2021 Irvin Jackson Add Your Comments A United States Senate committee passed a bill this week, providing rare bipartisan support for legislation designed to protect emergency first responders from toxic chemicals in firefighting foam, which has been linked to an increased risk of cancer and other health problems. If passed into law, the legislation would direct the Federal Emergency Management Agency to develop guidance on how to protect emergency response personnel from exposure to per and polyfluoroalkyl substances (PFAS); toxic chemicals often found in aqueous film-forming foams used to fight certain types of fires, as well as other protective equipment. Known as the “Protecting Firefighters from Adverse Substances Act” (S.231), the bill has become more commonly known as the “PFAS Act”, and also includes guidance on developing firefighter foam and personal protective equipment that does not include the toxic chemicals, which resist heat, grease, stains and water. Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The bill was originally introduced in 2019, but failed to move forward. However, amid growing concerns about the health risks associated with PFAS, and a mounting number of firefighter cancer lawsuits being filed against manufacturers of the chemicals, it was reintroduced in this latest legislative session. On March 17 the bill received a big boost as it was approved boy the Senate Committee on Homeland Security & Governmental Affairs with a unanimous bipartisan vote. The approval came after the bill’s sponsor, Senator Gary Peters of Michigan, chairman of the Homeland Security Committee, released a report by the Government Accountability Office (GAO), which urged congress to take action on preventing and addressing PFAS contamination, which is also a threat to drinking water supplies due to contamination from nearby military bases, which use large amounts of the firefighter foam. “Exposure to PFAS chemicals continues to harm the health and wellbeing of families in Michigan and across America,” Senator Peters said in a press release. “This report clearly shows that while progress is being made, the federal government must step up their efforts to ensure our drinking water is safe and protect communities from these hazardous chemicals.” PFAS and Firefighter Foam Environmental Concerns PFAS were first introduced into the manufacturing industry in the 1940’s, and have been widely used in firefighting foam, personal protective equipment and other food packaging, including pizza boxes, popcorn backs, non-stick cooking pans and other products. However, since then the chemicals have been linked to a myriad of adverse health effects including liver damage, thyroid disease, decreased fertility, high cholesterol, obesity, hormone suppression, and cancer. It is projected to take thousands of years for PFAS to degrade, and past studies have shown their ability to enter and stay in the environment and human body through the air, dust, food, soil, and water. Previous U.S. Centers for Disease Control and Prevention studies have shown PFAS chemicals primarily settle into the blood, kidney and liver, and could likely be detected in the blood of 98% of the U.S. population. Firefighting foam is widely cited as one of the leading causes of PFAS exposure, not only among firefighters, but also among residents living near military bases, airports and other locations where AFFF was routinely used during training and response exercises. Chemical manufacturers now face a growing number of lawsuits brought by individuals diagnosed with cancer and other disease, as well as local water supply entities, which now bear the costs of attempting to clean up PFAS that has contaminated ground water supplies. The legislation still needs to pass the full Senate, the U.S. House of Representatives, and then would need to be signed into law by President Joe Biden before being enacted. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Chemicals, Congress, Drinking Water, Firefighter, Firefighter Foam, PFAS Find Out If You Qualify for A AFFF Lawsuit Settlement More Firefighting Foam Lawsuit Stories Three AFFF Ulcerative Colitis Lawsuits Selected for Tier 2 Bellwether Trials September 16, 2025 Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025 PFAS Water Contamination Map Shows States With Highest ‘Forever Chemicals’ August 22, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 2 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 3 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 6 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 2 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 3 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 6 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)